Waters Corporation (WAT)

Currency in USD
328.14
-53.15(-13.94%)
Closed·
328.70+0.56(+0.17%)
·
Earnings results expected today
Unusual trading volume
WAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
326.24344.97
52 wk Range
275.05414.15
Key Statistics
Prev. Close
381.29
Open
332.29
Day's Range
326.24-344.97
52 wk Range
275.05-414.15
Volume
2.55M
Average Vol. (3m)
575.6K
1-Year Change
-19.8681%
Book Value / Share
39.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
416.94
Upside
+27.06%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Waters Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Waters Corporation Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation SWOT Analysis


Growth Catalysts
Biologics market's 10.3% CAGR through 2028 and GLP-1 treatments' 25%+ growth rate provide tailwinds for Waters' ambitious expansion strategy
Market Dynamics
Waters' expanded portfolio strengthens its competitive edge, with analysts noting a potential upside due to current valuation gap compared to industry peers
Financial Prospects
Projected free cash flow to double by 2027, with adjusted EBITDA margins exceeding 31% and potential for substantial borrowing capacity for future growth
Strategic Expansion
Waters Corporation's acquisition of BDX's Biosciences & Dx business positions it for significant growth in pharmaceutical and biotechnology manufacturing sectors
Read full SWOT analysis

Waters Corporation Earnings Call Summary for Q4/2025

  • Waters Corp. reported Q4 2025 adjusted EPS of $4.53 (beating $4.51 forecast) and revenue of $932M (exceeding $928.09M expectations), yet stock fell 14.49% to $326.04 pre-market.
  • Revenue grew 7% year-over-year with strong performance from Alliance iS HPLC and Xevo TQ Absolute platforms; full-year adjusted EPS rose 11% to $13.13.
  • The company completed a significant acquisition of BD's Biosciences and Diagnostic Solutions, which is expected to contribute $3B in revenue.
  • For 2026, Waters projects organic constant currency revenue growth of 5.5-7%, with total revenue guidance of $6.405-6.455B and adjusted EPS of $14.30-14.50.
  • CEO Udit Batra described the BD integration as creating 'a scientific powerhouse' and characterized the 5.3% midpoint growth outlook as 'appropriately prudent, yet industry-leading.'
Last Updated: 02/09/2026, 09:55 AM
Read Full Transcript
Waters investor slides for Q4/2025
Waters Q4 2025 presentation highlights growth strategy as stock tumbles
Last Update: Feb 09, 2026
See full investor slides

Compare WAT to Peers and Sector

Metrics to compare
WAT
Peers
Sector
Relationship
P/E Ratio
35.0x23.7x−0.5x
PEG Ratio
8.090.780.00
Price / Book
9.7x4.0x2.6x
Price / LTM Sales
7.3x2.2x3.3x
Upside (Analyst Target)
22.7%28.4%45.6%
Fair Value Upside
Unlock10.8%5.8%Unlock

Analyst Ratings

9 Buy
11 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 416.94
(+27.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Evercore ISI
Hold360.00+9.71%-New CoverageFeb 10, 2026
Stifel
Hold---MaintainFeb 09, 2026
HSBC
Buy460.00+40.18%-New CoverageJan 27, 2026
Guggenheim
Buy440.00+34.09%-New CoverageJan 06, 2026
William Blair
Buy---New CoverageJan 05, 2026

Earnings

Latest Release
Feb 09, 2026
EPS / Forecast
4.53 / 4.51
Revenue / Forecast
932.00M / 928.09M
EPS Revisions
Last 90 days

WAT Income Statement

People Also Watch

127.30
ZTS
-0.09%
225.76
CAH
-0.25%
285.99
WDC
+1.21%
425.00
STX
-1.01%

FAQ

What Is the Waters (WAT) Stock Price Today?

The Waters stock price today is 328.14

What Stock Exchange Does Waters Trade On?

Waters is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Waters?

The stock symbol for Waters is "WAT."

What Is the Waters Market Cap?

As of today, Waters market cap is 22.70B.

What Is Waters's Earnings Per Share (TTM)?

The Waters EPS (TTM) is 10.88.

When Is the Next Waters Earnings Date?

Waters will release its next earnings report on Feb 09, 2026.

From a Technical Analysis Perspective, Is WAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Waters Stock Split?

Waters has split 2 times.

How Many Employees Does Waters Have?

Waters has 7600 employees.

What is the current trading status of Waters (WAT)?

As of Feb 10, 2026, Waters (WAT) is trading at a price of 328.14, with a previous close of 381.29. The stock has fluctuated within a day range of 326.24 to 344.97, while its 52-week range spans from 275.05 to 414.15.

What Is Waters (WAT) Price Target According to Analysts?

The average 12-month price target for Waters is USD416.94, with a high estimate of USD480 and a low estimate of USD349. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +27.06% Upside potential.

What Is the WAT Premarket Price?

WAT's last pre-market stock price is 326.04. The pre-market share volume is 39,700.00, and the stock has decreased by -55.25, or -14.49%.

What Is the WAT After Hours Price?

WAT's last after hours stock price is 328.70, the stock has decreased by 0.56, or 0.17%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.